Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Translational research : the journal of laboratory and clinical medicine
- Publicado em
- 20 jan 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis
Stefania Bunduc, Noémi Gede, Szilárd Váncsa, Veronika Lillik, Szabolcs Kiss, Márk Félix Juhász, Balint Eross, Zsolt Szakács, Cristian Gheorghe, Alexandra Mikó et al.
Descritores MeSH
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Exosomes
- Humans
- Prognosis
- Biomarkers, Tumor
Veja também
Estudos relacionados
- Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer
- Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis
- Prognostic value of miR-21 in colorectal cancer, pancreatic ductal adenocarcinoma, and esophageal squamous cell carcinoma: updated systematic review and meta-analysis
- Exosomal RNA biomarkers in pancreatic ductal adenocarcinoma: Systematic review and meta-analysis